Stock A352480 C&C INTERNATIONAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings C&C International Co., Ltd.

Equities

A352480

KR7352480008

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-06-09 pm EDT 		5-day change 1st Jan Change
94,500 KRW +7.14% Intraday chart for C&C International Co., Ltd. +3.28% +51.44%
2023 C&C International Co., Ltd. announced that it has received KRW 30 billion in funding CI
2023 C&C International Co., Ltd. announced that it expects to receive KRW 30 billion in funding CI

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
  • The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

  • The prospective high growth for the next fiscal years is among the main assets of the company
  • Thanks to a sound financial situation, the firm has significant leeway for investment.
  • Over the past year, analysts have regularly revised upwards their sales forecast for the company.
  • Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
  • For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
  • For the past twelve months, EPS forecast has been revised upwards.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • Over the past four months, analysts' average price target has been revised upwards significantly.
  • Consensus analysts have strongly revised their opinion of the company over the past 12 months.
  • Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
  • The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.

Weaknesses

  • The company appears highly valued given the size of its balance sheet.
  • The valuation of the company is particularly high given the cash flows generated by its activity.
  • The average consensus view of analysts covering the stock has deteriorated over the past four months.

Ratings chart - Surperformance

Sector: Personal Products

1st Jan change Capi. Investor Rating ESG Refinitiv
C&C INTERNATIONAL CO., LTD. Stock C&C International Co., Ltd.
+51.44% 687M -
KAO CORPORATION Stock Kao Corporation
+16.33% 19.96B
B+
GALDERMA GROUP AG Stock Galderma Group AG
0.00% 19.45B - -
SHISEIDO COMPANY, LIMITED Stock Shiseido Company, Limited
+19.21% 12.92B
A-
COTY INC. Stock Coty Inc.
-20.77% 8.49B
A-
AMOREPACIFIC CORPORATION Stock Amorepacific Corporation
+21.45% 7.85B
B+
PROYA COSMETICS CO.,LTD. Stock Proya Cosmetics Co.,Ltd.
+9.98% 5.95B
B
NATURA &CO HOLDING S.A. Stock Natura &Co Holding S.A.
-12.08% 3.9B
B+
KOSÉ CORPORATION Stock KOSÉ Corporation
-1.37% 3.82B
B
INTER PARFUMS, INC. Stock Inter Parfums, Inc.
-20.29% 3.68B
C-
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
-
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
  1. Stock Market
  2. Equities
  3. A352480 Stock
  4. Ratings C&C International Co., Ltd.